Table 2.
Results of stepwise regression analysis for the number of respiratory drugs in patients with COPD
Model | Unstandardized coefficients | Standardized coefficients | t | Significance | |
---|---|---|---|---|---|
B | Standard error | Beta | |||
(Constant) | 6.015 | 0.777 | 7.742 | 0.000 | |
SGRQ total | 0.15 | 0.003 | 0.183 | 4.535 | 0.000 |
FEV1, % pred | −0.18 | 0.003 | −0.233 | −5.484 | 0.000 |
Exacerbations, no | 0.095 | 0.020 | 0.170 | 4.663 | 0.000 |
6MWD, meters | −0.002 | 0.000 | −0.139 | −3.467 | 0.001 |
PaCO2, kPa | 0.320 | 0.087 | 0.149 | 3.653 | 0.000 |
DLCO, % pred | 0.009 | 0.003 | 0.124 | 3.166 | 0.002 |
PaO2, kPa | −0.100 | 0.041 | −0.097 | −2.428 | 0.015 |
Abbreviations: SGRQ, St George’s Respiratory Questionnaire; FEV1, forced expiratory volume in one second; 6MWD, six-minute walk distance; PaCO2, arterial carbon dioxide tension; DLCO, diffusing capacity for carbon monoxide; PaO2, arterial oxygen tension.